+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Maxillary Sinusitis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767911
  • Report
  • April 2019
  • Region: Global
  • 36 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Alkem Laboratories Ltd
  • Aurobindo Pharma Ltd
  • Bayer AG
  • Biotec Pharmacon ASA
  • HEC Group
  • Novartis AG
  • MORE
The global clinical trial report- “2019 Maxillary Sinusitis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Maxillary Sinusitis. It presents in-depth analysis of Maxillary Sinusitis clinical trials across markets and companies. The research work is for providing complete understanding into trends in Maxillary Sinusitis.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Maxillary Sinusitis clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Maxillary Sinusitis

The research work is prepared through extensive and continuous research on Maxillary Sinusitis trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Maxillary Sinusitis patients are identified
  • The report includes panorama of Maxillary Sinusitis clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Maxillary Sinusitis clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Alkem Laboratories Ltd
  • Aurobindo Pharma Ltd
  • Bayer AG
  • Biotec Pharmacon ASA
  • HEC Group
  • Novartis AG
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Maxillary Sinusitis Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Maxillary Sinusitis Clinical Trials by Region
2.2.2 Average Enrollment of Maxillary Sinusitis Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Maxillary Sinusitis Treatment, 2019

3. Region wise Maxillary Sinusitis Clinical Trials
3.1 Asia Pacific Maxillary Sinusitis Clinical Trials by Country
3.2 Europe Maxillary Sinusitis Clinical Trials by Country
3.3 North America Maxillary Sinusitis Clinical Trials by Country
3.4 Middle East and Africa Maxillary Sinusitis Clinical Trials by Country
3.5 South and Central America Maxillary Sinusitis Clinical Trials by Country

4. Maxillary Sinusitis Clinical Trial Trends
4.1 Start Year wise Maxillary Sinusitis Clinical Trials
4.2 Phase wise Maxillary Sinusitis Clinical Trials
4.3 Trial Status wise Maxillary Sinusitis Clinical Trials
4.4 Trial Type wise Maxillary Sinusitis Clinical Trials

5. Maxillary Sinusitis Average Enrollment Trends
5.1 Average Enrollment in Maxillary Sinusitis Trials by Year
5.2 Average Enrollment in Maxillary Sinusitis Trials by Phase
5.3 Average Enrollment in Maxillary Sinusitis Trials by Status
5.4 Average Enrollment in Maxillary Sinusitis Trials by Type of Trial

6. Companies Participating in Maxillary Sinusitis Clinical Trials
6.1 Maxillary Sinusitis Trials by Sponsor Type
6.2 Maxillary Sinusitis Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Maxillary Sinusitis Trials- Phase 1
7.2 Maxillary Sinusitis Trials- Phase 2
7.3 Maxillary Sinusitis Trials- Phase 3
7.4 Maxillary Sinusitis Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Maxillary Sinusitis Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Maxillary Sinusitis Clinical Trials and Enrolment
Figure 5: Europe - Country wise Maxillary Sinusitis Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Maxillary Sinusitis Clinical Trials and Enrolment
Figure 7: North America - Country wise Maxillary Sinusitis Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Maxillary Sinusitis Clinical Trials and Enrolment
Figure 9: Maxillary Sinusitis Clinical Trials by Phase
Figure 10: Maxillary Sinusitis Clinical Trials by Trial Status
Figure 11: Maxillary Sinusitis Clinical Trials by Type
Figure 12: Maxillary Sinusitis Clinical Trials by Sponsor Type
Figure 13: Maxillary Sinusitis Clinical Trials by Leading Sponsors
Figure 14: Maxillary Sinusitis Average Enrollment by Phase
Figure 15: Maxillary Sinusitis Average Enrollment by Trial Status
Figure 16: Maxillary Sinusitis Average Enrollment by Type
Figure 17: Maxillary Sinusitis- Average Enrolment by Type of Sponsors
Figure 18: Maxillary Sinusitis- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Maxillary Sinusitis Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Maxillary Sinusitis Clinical Trials and Enrolment
Table 5: Europe - Country wise Maxillary Sinusitis Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Maxillary Sinusitis Clinical Trials and Enrolment
Table 7: North America - Country wise Maxillary Sinusitis Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Maxillary Sinusitis Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Maxillary Sinusitis Average Enrollment by Phase
Table 15: Maxillary Sinusitis Average Enrollment by Trial Status
Table 16: Maxillary Sinusitis Average Enrollment by Type
Table 17: Maxillary Sinusitis- Average Enrolment by Type of Sponsors
Table 18: Maxillary Sinusitis- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3
  • Alkem Laboratories Ltd
  • Aurobindo Pharma Ltd
  • Bayer AG
  • Biotec Pharmacon ASA
  • HEC Group
  • Lambda Therapeutic Research Ltd
  • Novartis AG
  • Pfizer Inc
  • Sanofi
  • SFBC Anapharm
Note: Product cover images may vary from those shown
Adroll
adroll